Drug
Iron isomaltoside 1000 clinical trials
Also written Monofer.
- studies test it
- 54
- open now
- 8
- in phase 3
- 25
- first study started
- 2007
Keep track of what changes. Save the iron isomaltoside 1000 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
- Monofer
- 26
Studies by the year they started
53 studies that test it; most in 2017 (8)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 25
- Phase 4
- 12
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 27 · Other 27
Pharmacosmos A/S (27) · Yonsei University (5) · Oslo University Hospital (2) · Thomas Jefferson University (1) · University Medical Centre Ljubljana (1) · Universität des Saarlandes (1) · Prince of Wales Hospital, Shatin, Hong Kong (1) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Ferric derisomaltose (6) · Ferric carboxymaltose (3) · Iron sucrose (3) · Ferrous fumarate (1) · Tranexamic Acid (1)
Studies
Open first, then newest update. How each study uses iron isomaltoside 1000 is read from its arms, and is right about nine times in ten.
Testing it · 54
- Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN StudyRecruitingPhase 3Hull University Teaching Hospitals NHS TrustNCT06884280Written as Monofer (iron isomaltoside 1000)
- Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.RecruitingNot applicableChina-Japan Friendship HospitalNCT07236788Written as Iron Isomaltoside injection
- Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyRecruitingPhase 3Saskatchewan Health Authority - Regina AreaNCT05251493Written as Iron Isomaltoside 1000, ferric derisomaltose
- Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis PatientsNot yet recruitingPhase 4Xie Jingyuan, MDNCT06830941Written as Iron isomaltoside
- IV Iron-induced Hypophosphatemia After RYGBRecruitingPhase 4Lucie FavreNCT06350955Written as Iron isomaltoside
- Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal CarcinomaRecruitingPhase 2Sun Yat-sen UniversityNCT05913414Written as Iron Isomaltoside 1000
- The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant OutcomesNot yet recruitingPhase 4Yonsei UniversityNCT05719376Written as Monofer (experimental)
- Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.RecruitingNot applicableLeiden University Medical CenterNCT05581420Written as MonoFer
- Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic StenosisCompletedPhase 2Oslo University HospitalNCT04206228Written as Intravenous iron isomaltoside
- Reducing Anemia in Pregnancy in India: the RAPIDIRON TrialCompletedPhase 4Thomas Jefferson UniversityNCT05358509Written as Iron isomaltoside
- HiFIT Study : Hip Fracture: Iron and Tranexamic AcidTerminatedPhase 3University Hospital, AngersNCT02972294Written as Iron Isomaltoside 1000
- Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum AnemiaCompletedPhase 3University Medical Centre LjubljanaNCT03957057Written as Iron Isomaltoside
- Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis PatientsTerminatedNot applicableThe University of Hong KongNCT03610230Written as Iron Isomaltoside
- Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant RecipientsCompletedPhase 2/3Oslo University HospitalNCT03662789Written as Iron Isomaltoside 1000
- A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel DiseaseCompletedPhase 4Pharmacosmos A/SNCT03466983Written as Iron Isomaltoside
- A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or MonoferCompletedPhase 4Universität des SaarlandesNCT02905539Written as Iron Isomaltoside 1000
- Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.CompletedPhase 4Pharmacosmos A/SNCT03188445Written as Iron Isomaltoside 1000
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney DiseaseCompletedPhase 3Pharmacosmos A/SNCT02940860Written as Iron isomaltoside/ferric derisomaltose
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)CompletedPhase 3Pharmacosmos A/SNCT02940886Written as Iron isomaltoside/ferric derisomaltose
- Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical TrialCompletedNot applicableYonsei UniversityNCT02862665Written as iron isomaltoside 1000 (Monofer®)
See all 54 studies that test iron isomaltoside 1000 →
As the comparator · 1 — what is tested is compared with iron isomaltoside 1000
Codes
What other systems call iron isomaltoside 1000 · ClinicalTrials.gg INT005816
- MeSH (NLM) C557707iron isomaltoside 1000Confirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3M6325NY1RIRON ISOMALTOSIDE 1000Confirmed FDA, NLM, Wikidata
- Wikidata Q112131611iron isomaltoside 1000Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C92584Iron Isomaltoside 1000Confirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C557707 | iron isomaltoside 1000 | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3M6325NY1R | IRON ISOMALTOSIDE 1000 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q112131611 | iron isomaltoside 1000 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C92584 | Iron Isomaltoside 1000 | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.